These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 30741560

  • 1. Neurofibromatosis Type 1: Description of a Novel Diagnostic Scoring System in Pediatric Optic Nerve Glioma.
    Eid H, Crevier-Sorbo G, Aldraihem A, Menegotto F, Wilson N.
    AJR Am J Roentgenol; 2019 Apr; 212(4):892-898. PubMed ID: 30741560
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of optic nerve diameters in individuals with neurofibromatosis and comparison of normative values in different pediatric age groups.
    Tosun M, Güngör M, Uslu H, Anık Y.
    Clin Imaging; 2022 May; 85():83-88. PubMed ID: 35259715
    [Abstract] [Full Text] [Related]

  • 3. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
    Wolsey DH, Larson SA, Creel D, Hoffman R.
    J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228
    [Abstract] [Full Text] [Related]

  • 4. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.
    Avery RA, Mansoor A, Idrees R, Biggs E, Alsharid MA, Packer RJ, Linguraru MG.
    Neurology; 2016 Jun 14; 86(24):2264-70. PubMed ID: 27170570
    [Abstract] [Full Text] [Related]

  • 5. Optic nerve tortuosity in children with neurofibromatosis type 1.
    Ji J, Shimony J, Gao F, McKinstry RC, Gutmann DH.
    Pediatr Radiol; 2013 Oct 14; 43(10):1336-43. PubMed ID: 23636538
    [Abstract] [Full Text] [Related]

  • 6. Anisometropia in children with neurofibromatosis type 1 and unilateral optic nerve glioma.
    Dotan G, Keren S, Stolovitch C, Toledano-Alhadef H, Kesler A.
    J AAPOS; 2014 Jun 14; 18(3):255-7. PubMed ID: 24924279
    [Abstract] [Full Text] [Related]

  • 7. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
    Levin MH, Armstrong GT, Broad JH, Zimmerman R, Bilaniuk LT, Feygin T, Li Y, Liu GT, Fisher MJ.
    Br J Ophthalmol; 2016 Apr 14; 100(4):510-4. PubMed ID: 26294105
    [Abstract] [Full Text] [Related]

  • 8. Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.
    Avery RA, Mansoor A, Idrees R, Trimboli-Heidler C, Ishikawa H, Packer RJ, Linguraru MG.
    Neurology; 2016 Dec 06; 87(23):2403-2407. PubMed ID: 27815398
    [Abstract] [Full Text] [Related]

  • 9. Comparison of multi-shot and single shot echo-planar diffusion tensor techniques for the optic pathway in patients with neurofibromatosis type 1.
    Ho CY, Deardorff R, Kralik SF, West JD, Wu YC, Shih CS.
    Neuroradiology; 2019 Apr 06; 61(4):431-441. PubMed ID: 30684113
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Defining optic nerve tortuosity.
    Armstrong GT, Localio AR, Feygin T, Bilaniuk L, Phillips PC, Fisher MJ, Strom BL, Zimmerman R.
    AJNR Am J Neuroradiol; 2007 Apr 06; 28(4):666-71. PubMed ID: 17416818
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in children.
    Marsault P, Ducassou S, Menut F, Bessou P, Havez-Enjolras M, Chateil JF.
    Neuroradiology; 2019 Jun 06; 61(6):711-720. PubMed ID: 30904949
    [Abstract] [Full Text] [Related]

  • 13. Neurofibromatosis type 1 and sporadic optic gliomas.
    Singhal S, Birch JM, Kerr B, Lashford L, Evans DG.
    Arch Dis Child; 2002 Jul 06; 87(1):65-70. PubMed ID: 12089128
    [Abstract] [Full Text] [Related]

  • 14. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital.
    Rony C, Aharoni S, Halevy A.
    Neuropediatrics; 2022 Oct 06; 53(5):370-375. PubMed ID: 35381604
    [Abstract] [Full Text] [Related]

  • 15. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.
    Cambiaso P, Galassi S, Palmiero M, Mastronuzzi A, Del Bufalo F, Capolino R, Cacchione A, Buonuomo PS, Gonfiantini MV, Bartuli A, Cappa M, Macchiaiolo M.
    Am J Med Genet A; 2017 Sep 06; 173(9):2353-2358. PubMed ID: 28631895
    [Abstract] [Full Text] [Related]

  • 16. Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI.
    Saraç Ö, Alğin O, Beyazal M, Anlar FB, Varan A, Kansu AT.
    Turk J Med Sci; 2019 Dec 16; 49(6):1626-1633. PubMed ID: 31655505
    [Abstract] [Full Text] [Related]

  • 17. Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma.
    Boonzaier NR, Hales PW, D'Arco F, Walters BC, Kaur R, Mankad K, Cooper J, Liasis A, Smith V, O'Hare P, Hargrave D, Clark CA.
    Neuroimage Clin; 2020 Dec 16; 28():102447. PubMed ID: 33038669
    [Abstract] [Full Text] [Related]

  • 18. Optic Gliomas in Neurofibromatosis Type 1.
    Parkhurst E, Abboy S.
    J Pediatr Ophthalmol Strabismus; 2016 Nov 01; 53(6):334-338. PubMed ID: 27537249
    [Abstract] [Full Text] [Related]

  • 19. Isolated optic nerve gliomas: a multicenter historical cohort study.
    Shofty B, Ben-Sira L, Kesler A, Jallo G, Groves ML, Iyer RR, Lassaletta A, Tabori U, Bouffet E, Thomale UW, Hernáiz Driever P, Constantini S, Isolated Optic Nerve Abnormalities (IONA) Collaboration.
    J Neurosurg Pediatr; 2017 Dec 01; 20(6):549-555. PubMed ID: 28984541
    [Abstract] [Full Text] [Related]

  • 20. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
    Trevisson E, Cassina M, Opocher E, Vicenzi V, Lucchetta M, Parrozzani R, Miglionico G, Mardari R, Viscardi E, Midena E, Clementi M.
    J Neurooncol; 2017 Sep 01; 134(2):279-287. PubMed ID: 28577031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.